NewcelX director buys shares and warrants
NewcelX Ltd. director Samuel Olivier reported open-market purchases of both common shares and warrants.
Rhea-AI Filing Summary
NewcelX Ltd. director Samuel Olivier reported open-market purchases of both common shares and warrants. He bought 81,818 common shares of NewcelX at $2.75 per share, with each share sold together with a warrant according to the footnote.
Olivier also acquired 114,545 warrants, each exercisable at $3.025 per common share and expiring on April 27, 2031. Following these transactions, he directly holds 81,818 common shares and 114,545 warrants, reflecting a net addition of 196,363 share-equivalents to his position.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Warrant (right to buy) | 114,545 | $0.00 | $0.00 |
| Purchase | Common Shares, par value CHF 0.05 per share | 81,818 | $2.75 | $225K |
Footnotes (1)
- F1. The combined purchase price per one common share, par value CHF 0.05 per share ("Common Share"), and accompanying one warrant to purchase Common Share was $2.75.
Key Figures
Key Terms
open-market purchase financial
warrant financial
par value financial
exercise price financial
derivative financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NewcelX (NCEL) director Samuel Olivier report?
What warrants did NewcelX (NCEL) director Samuel Olivier acquire?
What is the combined purchase structure noted in the NewcelX (NCEL) Form 4 footnote?
What are Samuel Olivier’s NewcelX (NCEL) holdings after these transactions?
When do Samuel Olivier’s NewcelX (NCEL) warrants expire and what is the exercise price?
AI-generated analysis. How Rhea-AI works. Not financial advice.